A global investigator meeting (IM) series for 300+ healthcare professionals (HCPs) held in North America, Europe and Asia.
Partner on a global R&D Initiative to redesign and reimagine investigator meeting format to develop the best HCP journey that includes content engagement with measured/reportable return on investment (ROI) metrics.
Improve the HCPs training process for a more successful clinical trial which included garnering metrics to measure overall HCP impression, training effectiveness; managing the investigator meeting series more systematically; optimizing the meeting agenda for better knowledge retention and content engagement; increasing attendance globally; automating a seamless registration process; and tracking and addressing deviations in real time.
Exceeded the event goal of 90% or higher positive response rate from HCPs who attended the investigator meeting for the global study.
Increased site representation and attendance globally to 87% (3-year average).
Reimagined agenda creation that would increase content engagement and maximize the face-to-face meeting. (93% NorthAM, 97% EU)
MTA’s Event Planning In Control (EPIC™) product, allowed for customized client event website where life science company’s clinical trial managers had the ability to manage the event seamlessly in real time, address deviations that occurred, chat with MTA team through built-in instant messaging, and track all changes throughout the meeting as they occurred.
ATTENDTM, MTA’s paperless meeting web app, made it easy for attendees to use their own device to follow their personalized agenda, interact with the presenters and MTA on-site team and submit expense reimbursement forms.
HCPs’ were reimbursed for approved incidental spend in their currency of choice within 3-5 business days with correctly submitted on-line form completion.
The use of the audience engagement platform provided a high level of interaction, allowing participants to ask questions and receive feedback live throughout the event. 92% or higher of HCPs reported that upon leaving the meeting they understood the expectations of their site and 93% or higher of the HCPs reported the content prepared them to conduct the trial.